X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SHASUN PHARMA with Orchid Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs ORCHID PHARMA LTD - Comparison Results

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA ORCHID PHARMA LTD SHASUN PHARMA/
ORCHID PHARMA LTD
 
P/E (TTM) x 123.9 -0.1 - View Chart
P/BV x 8.5 0.1 7,683.6% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 SHASUN PHARMA   ORCHID PHARMA LTD
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
ORCHID PHARMA LTD
Sep-13
SHASUN PHARMA/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs94194 48.6%   
Low Rs4635 130.3%   
Sales per share (Unadj.) Rs214.2276.5 77.5%  
Earnings per share (Unadj.) Rs5.3-79.2 -6.7%  
Cash flow per share (Unadj.) Rs15.8-43.5 -36.4%  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %1.40-  
Book value per share (Unadj.) Rs53.353.9 98.9%  
Shares outstanding (eoy) m56.6270.45 80.4%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.30.4 78.8%   
Avg P/E ratio x13.1-1.4 -906.2%  
P/CF ratio (eoy) x4.4-2.6 -167.7%  
Price / Book Value ratio x1.32.1 61.7%  
Dividend payout %18.70-   
Avg Mkt Cap Rs m3,9588,067 49.1%   
No. of employees `000NA2.8 0.0%   
Total wages/salary Rs m2,1642,527 85.6%   
Avg. sales/employee Rs ThNM6,956.1-  
Avg. wages/employee Rs ThNM902.5-  
Avg. net profit/employee Rs ThNM-1,993.0-  
INCOME DATA
Net Sales Rs m12,12719,477 62.3%  
Other income Rs m229407 56.3%   
Total revenues Rs m12,35619,884 62.1%   
Gross profit Rs m1,0091,103 91.5%  
Depreciation Rs m5942,519 23.6%   
Interest Rs m4155,227 7.9%   
Profit before tax Rs m230-6,236 -3.7%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m-73-125 58.1%   
Profit after tax Rs m302-5,580 -5.4%  
Gross profit margin %8.35.7 147.0%  
Effective tax rate %-31.72.0 -1,576.9%   
Net profit margin %2.5-28.7 -8.7%  
BALANCE SHEET DATA
Current assets Rs m6,88411,014 62.5%   
Current liabilities Rs m8,45632,060 26.4%   
Net working cap to sales %-13.0-108.1 12.0%  
Current ratio x0.80.3 237.0%  
Inventory Days Days6295 65.0%  
Debtors Days Days10834 320.5%  
Net fixed assets Rs m4,97029,440 16.9%   
Share capital Rs m113705 16.1%   
"Free" reserves Rs m2,8752,043 140.7%   
Net worth Rs m3,0203,800 79.5%   
Long term debt Rs m1,8179,018 20.2%   
Total assets Rs m13,34746,510 28.7%  
Interest coverage x1.6-0.2 -804.3%   
Debt to equity ratio x0.62.4 25.4%  
Sales to assets ratio x0.90.4 217.0%   
Return on assets %5.4-0.8 -707.0%  
Return on equity %10.0-146.9 -6.8%  
Return on capital %13.3-3.7 -356.7%  
Exports to sales %46.437.9 122.4%   
Imports to sales %14.222.6 63.0%   
Exports (fob) Rs m5,6227,378 76.2%   
Imports (cif) Rs m1,7284,406 39.2%   
Fx inflow Rs m5,8437,513 77.8%   
Fx outflow Rs m2,1735,649 38.5%   
Net fx Rs m3,6691,865 196.8%   
CASH FLOW
From Operations Rs m3981,682 23.6%  
From Investments Rs m-1,635-9,860 16.6%  
From Financial Activity Rs m1,3096,644 19.7%  
Net Cashflow Rs m71-1,535 -4.6%  

Share Holding

Indian Promoters % 39.2 32.3 121.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.6 4.6 78.3%  
FIIs % 17.6 3.3 533.3%  
ADR/GDR % 0.0 4.6 -  
Free float % 39.6 55.3 71.6%  
Shareholders   20,750 84,811 24.5%  
Pledged promoter(s) holding % 12.3 54.9 22.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   CIPLA  PIRAMAL ENTERPRISES  NATCO PHARMA  AUROBINDO PHARMA  PFIZER  

Compare SHASUN PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

From Urjit Patel to Shaktikanta Das; What Lies Ahead?(Podcast)

The week gone by saw Sensex plunge from 700 points to rise by over 600 points. With a volatile and eventful week, it was a challenge keeping up with the news every day.

Related Views on News

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

It's Almost the Perfect Time to Buy This Safe Stock(The 5 Minute Wrapup)

Dec 6, 2018

My latest StockSelect recommendation ticks all the boxes of a great safe stock.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

Are Foreign Investors Heading Back to the Indian Stock Markets?(Chart Of The Day)

Dec 3, 2018

After months of heavy FII selling, November witnessed a return on foreign money into Indian equities...

DSP Mutual Fund's Sale of DHFL Bonds: Here's What You Need to Know(Outside View)

Dec 5, 2018

PersonalFN explains the probable reason as to why the capital market regulator has initiated DSP Mutual Fund's bond sale that caused DHFL stock to crash.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 8-QTR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS